How to Distribute Veterinary Medicinal Active Substances
Apply the veterinary instrument, which is separate from its human counterpart.
What a how-to is not
A how-to is SPEQ’s practitioner method, not a procedure. It does not replace your own SOP, it is not a validated approach, and the judgement calls in it belong to your quality unit.
Active substances used in veterinary medicinal products are governed by their own EU distribution requirements. The material may be chemically identical to the human-use substance and arrive from the same manufacturer, but the applicable legal instrument follows the intended use rather than the molecule. This is a scope trap with no technical signal attached to it, which is why it is missed.
- 1
Determine the intended use, then the instrument
Establish whether the material is destined for veterinary or human medicinal products, because that determines which requirements apply. A distributor supplying both handles the same substance under two regimes and must be able to show which consignment sat under which.
- 2
Meet the registration and authorisation status the activity requires
Manufacture, import and distribution of veterinary active substances carry their own status obligations. Holding an authorisation on the human side does not confer standing on the veterinary side, and the two are assessed separately.
- 3
Maintain traceability to the manufacturing site
Records must let each batch be traced back to where it was made and forward to every recipient. The recall pathway for a veterinary product can run into food-producing animals, which makes the scoping question larger rather than smaller.
- 4
Control storage and transport for the material’s actual requirements
Bulk quantities, container integrity, and protection from contamination and cross-contamination. Veterinary bulk materials are frequently handled in larger volumes and in less controlled facilities than their human counterparts, which is a risk to design against rather than to inherit.
- 5
Verify customers are entitled to receive veterinary active substances
The entitlement is specific to the veterinary regime. A customer authorised to receive human-use active substances is not thereby entitled to receive veterinary ones, and the check has to be against the right register.
- 6
Plan recall with the food chain in view
A recall may need to reach animals already treated and product already entering the food chain. Build the notification path to reach veterinarians and producers, not only the manufacturing customer — that is where the exposure actually sits.
- !The human-use instrument applied because the substance is chemically identical.
- !Veterinary standing assumed from a human-side authorisation, which does not confer it.
- !Recall planning that stops at the manufacturing customer, when treated animals are the real exposure.
- !Bulk handling in facilities designed for a different risk profile, with no contamination controls added.
How to Distribute Veterinary Medicinal Active Substances: frequently asked questions
Common questions on distribute veterinary medicinal active substances.
Why does an identical substance follow different rules?
Because regulation follows intended use, not chemistry. The same molecule destined for a veterinary medicinal product sits under the veterinary instrument. Nothing about the material signals which applies, which makes this a scope error that no specification review will catch.
What if a distributor supplies both markets?
Then both sets of requirements apply to their respective consignments, and the distributor must be able to demonstrate which material was handled under which. That is a records and segregation design decision made in advance, not a determination made retrospectively when an inspector asks.
What makes veterinary recall different?
Its reach. A recall may need to extend to animals already treated and to product entering the human food chain, so notification runs to veterinarians and producers rather than stopping at the manufacturing customer. Planning a recall path that ends at your direct customer leaves the actual exposure unaddressed.